Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes

Abstract

Genomic alterations in advanced BTC were associated with specific prognosis and immunotherapy outcomes. Combining genomic classification with TME evaluation further improved the stratification of immunotherapy outcomes.